In Depth 20 Jan 2025
Is biotech M&A set to surge in 2025?
There is big hope for biotech M&A in 2025, with a resounding sense that activity will rise again as several important factors come into play.
Mergers & acquisitions
- Latest Posts
News and Trends 16 Jan 2025
Top biotech deals of December 2024
The month of December saw a variety of biotech deals take place to advance therapies across different stages in development.
In Depth 13 Jan 2025
2025 predictions: Which trends are set to shape the biotech industry this year?
From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025.
Partnering 2030: Biopharma Report
Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms.
News and Trends 2 Jan 2025
A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development
Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK.
News and Trends 12 Dec 2024
Top biotech deals of November 2024
November has seen a variety of biotech deals take place to advance therapies across different stages in development.
ADVERTISEMENT
ADVERTISEMENT
Podcast 6 Dec 2024
Cracking the code of biotech valuations
Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom.
News and Trends 25 Nov 2024
Evotec on the brink of acquisition: At what cost for the biotech industry?
As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape.
News and Trends 4 Nov 2024
Top biotech deals of October 2024
Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.
News and Trends 10 Oct 2024
Second biotech IPO boom of the year: what does it mean for the industry?
Discover why biotech is experiencing a second IPO boom in 2024 and what it means for the broader industry.
In Depth 8 Oct 2024
Top biotech deals of September 2024
There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month.
News and Trends 12 Sep 2024
Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges
Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D.
ADVERTISEMENT
